Policy Matters

Patient advocates strengthen every aspect of research, from funding innovative science and informing research design, to leading efforts on Capitol Hill to build support for research.

by Carrie Treadwell, MBA

A symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.

by Eric Fitzsimmons

Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.

by Marci A. Landsmann

An AACR Annual Meeting 2022 session highlights the impact of research advocacy partnerships for a variety of cancers.

by Marci A. Landsmann

Expansions in coverage and eligibility through the Affordable Care Act have made Medicaid a lifeline for many people with cancer, but benefits vary from state to state.

by Sharon Tregaskis

Forward Look

Medical oncologist Lola Fashoyin-Aje describes the Food and Drug Administration’s efforts to make clinical trials more inclusive.

by Erin O'Donnell

Facts and Stats

More people in the U.S. are alive after being diagnosed with cancer than ever before.

by Eric Fitzsimmons

Policy Matters

The AACR is engaging with Congress and the Biden administration on the importance of funding for cancer research.

by David A. Tuveson, MD, PhD

Get Involved

A volunteer program brings yoga to cancer patients in the hospital.

by Bradley Jones

People take cannabis to treat an array of cancer-related symptoms and side effects. Legal prohibitions have stymied attempts at research into cannabis in cancer patients, but doctors are finding creative ways to study its effects.

by Kate Yandell